Top 10 NEWStat stories of 2023
Surgery to treat herniated discs in dogs can cost up to $12,000 and result in weeks of painful recovery for the patient. A clinical trial at Texas A&M is testing a nonsurgical outpatient treatment that is far less expensive and less invasive.
More than 700 cities have breed bans or restrictions to attempt to reduce dog bite injuries, but many veterinary professionals believe these types of regulations do more harm than good.
The US Food and Drug Administration’s expanded conditional approval policy is meant to expedite the process for innovative and novel treatments of serious and life-threatening diseases and conditions in major species, including horses, cattle, pigs, dogs, cats, chickens, and turkeys.
There are more than 5,000 approved prescription and over-the-counter medications with labeled indications for veterinary patients. And a number of those products pose a health hazard to humans.
The term neurodiversity came about in the 1990s and is often used in the context of autism spectrum disorder, ADHD, dyslexia, bipolar disorder, and other neurological or developmental conditions. NEWStat contributor Wendy Ringie breaks down the idea of neurodivergence, the most common conditions, and what having a “different” brain means for you, your teammates, and your clients.
As the FDA’s new guidance about compounded drugs (GFI-256) went into effect April 1, 2023, some substances could have become harder to get or more expensive for clients.
Tierra Price, DVM, MPH, founder of BlackDVM Network, introduces us to 10 Black heroes of the veterinary profession who make a difference both inside and outside the veterinary practice in diverse sectors of the field ranging from academia and research to agriculture, leadership, administrative support, and media.
The USDA has granted a conditional license to the first Canine Parvovirus Monoclonal Antibody (CPMA) treatment from Elanco, which stands to be a “gamechanger” in fighting this deadly, highly transmissible disease.
Nearly 40% of dogs show signs of canine osteoarthritis (OA), but many don’t receive treatment. That could change with the newly FDA-approved Librela, a monthly injectable that has been used by veterinarians in Europe for the past two years with largely positive results.
Bexacat is the first oral drug treatment of diabetes in cats and offers an alternative to insulin injections—but veterinarians must choose the right patients due to important safety considerations.
Thank you for reading NEWStat! Got a great tip or story idea? Let us know at [email protected].
Disclaimer: The views expressed, and topics discussed, in any NEWStat column or article are intended to inform, educate, or entertain, and do not represent an official position by the American Animal Hospital Association (AAHA) or its Board of Directors.